These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23778007)

  • 1. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
    Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
    J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
    Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.
    Zhang BL; Ye Z; Xu RL; You XH; Qin YW; Wu H; Cao J; Zhang JL; Zheng X; Zhao XX
    Clin Genet; 2014 Sep; 86(3):287-91. PubMed ID: 23992123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel, de novo mutation in the
    Xu Y; Gray A; Hardie DG; Uzun A; Shaw S; Padbury J; Phornphutkul C; Tseng YT
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H283-H292. PubMed ID: 28550180
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
    Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
    Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
    Miyamoto L
    J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Daniel T; Carling D
    J Biol Chem; 2002 Dec; 277(52):51017-24. PubMed ID: 12397075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.
    Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR
    Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
    Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
    Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
    Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
    Zhan Y; Sun X; Li B; Cai H; Xu C; Liang Q; Lu C; Qian R; Chen S; Yin L; Sheng W; Huang G; Sun A; Ge J; Sun N
    J Mol Cell Cardiol; 2018 Apr; 117():49-61. PubMed ID: 29452156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome.
    Xie C; Zhang YP; Song L; Luo J; Qi W; Hu J; Lu D; Yang Z; Zhang J; Xiao J; Zhou B; Du JL; Jing N; Liu Y; Wang Y; Li BL; Song BL; Yan Y
    Cell Res; 2016 Oct; 26(10):1099-1111. PubMed ID: 27573176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
    Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
    PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
    J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial Lesions in a Pedigree With
    Chen S; Lin Y; Zhu Y; Geng L; Cui C; Li Z; Liu H; Chen H; Ju W; Chen M
    Front Cardiovasc Med; 2022; 9():840337. PubMed ID: 35360035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
    Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
    Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
    Ahmad F; Arad M; Musi N; He H; Wolf C; Branco D; Perez-Atayde AR; Stapleton D; Bali D; Xing Y; Tian R; Goodyear LJ; Berul CI; Ingwall JS; Seidman CE; Seidman JG
    Circulation; 2005 Nov; 112(20):3140-8. PubMed ID: 16275868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.
    Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H; Gorham J; Burke MA; Zhang K; Musunuru K; Gerszten RE; Wu SM; Chen CS; Seidman JG; Seidman CE
    Cell Rep; 2016 Dec; 17(12):3292-3304. PubMed ID: 28009297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.